Name: Guarding Against Pertussis. The Efficacy and Advantages of the TdaP Vaccine (en Inglés)
Price: 233.11 PEN
Availability: InStock
Author: Praveen Kumar Vemuri, Hyacinthe Tuyubahe
ISBN: 9783346908599

portada Guarding Against Pertussis. The Efficacy and Advantages of the TdaP Vaccine (en Inglés)

Formato

Libro Físico

Autor

Hyacinthe Tuyubahe Praveen Kumar Vemuri

Editorial

Grin Verlag

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

21.0 x 14.8 x 0.3 cm

Peso

0.07 kg.

ISBN13

9783346908599

Categorías

Ciencias básicas de la medicina preclínica
Tecnología: cuestiones generales
Biotecnología

Guarding Against Pertussis. The Efficacy and Advantages of the TdaP Vaccine (en Inglés)

Hyacinthe Tuyubahe Praveen Kumar Vemuri (Autor) · Grin Verlag · Tapa Blanda

Libro Nuevo

S/ 233,11

S/ 388,51

Ahorras: S/ 155,40

40% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 19 de Julio y el Martes 30 de Julio.

Lo recibirás en cualquier lugar de Perú entre 2 y 5 días hábiles luego del envío.

Reseña del libro "Guarding Against Pertussis. The Efficacy and Advantages of the TdaP Vaccine (en Inglés)"

Scientific Study from the year 2023 in the subject Medicine - Biomedical Engineering, grade: 3, language: English, abstract: This paper aims to elucidate the importance of TdaP vaccines in the prevention of pertussis, highlight the increased risk of this disease in adults, and underscore the benefits of using acellular vaccines over whole-cell vaccines. This text underscores the escalating threat of Pertussis (whooping cough) in adults and its lethal repercussions on infants with lesser immunity. This has led to innovations in vaccine development, particularly the emergence of acellular vaccines like the TdaP vaccine that effectively combats Tetanus, Diphtheria, and Pertussis. This vaccine offers the advantage of fewer side effects compared to whole-cell vaccines and contains purified antigenic components of Bordetella pertussis obtained through various purification techniques. The increased risk of pertussis in adults have become an important public-health issue. This contagious disease spreads to infants who have lesser immunity resulting in their death. Increased death rate caused the inventions of vaccinations to prevent this disease. Concerns regarding the safety of whole-cell vaccines used for pertussis treatment lead to the development of acellular pertussis vaccines like TdaP vaccines. This combination vaccine is 71-85% effective in the treatment of adults suffering from diseases tetanus, diphtheria and pertussis. These vaccines have limited side effects when compared to whole-cell vaccines as they contain purified antigenic components of Bordet Ella pertussis (Pertussis toxin, Filamentous hemagglutinin and Pertactin) that are obtained by the purification techniques Tangential flow filtration, Column Chromatography and Dialysis. These components are then formulated for purified vaccine production.